Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01957722 · ClinicalTrials.gov registry record · Phase 3
NOVOCART®3D for Treatment of Articular Cartilage of the Knee
A Phase 3 study of Articular Cartilage of the Femoral Condyle Between 2-6cm2, sponsored by Aesculap Biologics.
- Active
- Registry status
- Phase 3
- Development phase
- 233
- Enrollment target
- 20
- Study locations
NCT01957722 is a Phase 3 study of Articular Cartilage of the Femoral Condyle Between 2-6cm2 that is active but no longer recruiting, run by Aesculap Biologics. The registered enrollment target is 233 participants. The trial reports 20 study locations across 12 states.
The verdict
NCT01957722, a Phase 3 study of Articular Cartilage of the Femoral Condyle Between 2-6cm2, is active but no longer recruiting, sponsored by Aesculap Biologics.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 233 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is to compare NOVOCART 3D relative to Microfracture for the treatment of knee cartilage defects. Efficacy will be evaluated by both pain and function. Safety will also be evaluated.
Conditions Studied
Interventions
- PROCEDURE Microfracture
- BIOLOGICAL NOVOCART 3D
Study Locations (20)
California
- Grossmont Orthopaedic Medical Group - La Mesa
- UCLA - Los Angeles
- Stanford Medicine - Redwood City
New York
- Mount Sinai Faculty Practice Associates - New York
- Plancher Orthopaedics & Sports Medicine - New York
- Long Island Bone and Joint Llp - Port Jefferson
Colorado
- Cu Sports Medicine - Denver
- Yampa Valley Medical Center - Steamboat Springs
Florida
- Tenet Florida Physician Services - Boca Raton
- Paley Orthopedic and Spine Institute - West Palm Beach
Illinois
- Rush University Medical Center - Chicago
- Northshore University Health System - Evanston
Minnesota
- Tria Orthopaedic Center - Bloomington
- Mayo Clinic - Rochester
Idaho
- Saint Alphonsus Medical Group - Meridian
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2013-12 |
| Est. Completion | 2027-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01957722
The ClinicalTrials.gov registry entry for NCT01957722 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 233 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aesculap Biologics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Articular Cartilage of the Femoral Condyle Between 2-6cm2 appearing as the primary indexed condition, and to 2 interventions - of which Microfracture is the first listed.
NCT01957722 reports 20 study locations spanning 12 distinct geographic areas - top geographies include California, New York, Colorado.
Frequently Asked Questions
What is clinical trial NCT01957722 about?
NCT01957722 is a clinical study titled "NOVOCART®3D for Treatment of Articular Cartilage of the Knee". This study is to compare NOVOCART 3D relative to Microfracture for the treatment of knee cartilage defects. Efficacy will be evaluated by both pain and function. Safety will also be evaluated.
What is the current status of trial NCT01957722?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 233 participants. The study started on 2013-12. Estimated completion is 2027-12.
What conditions does trial NCT01957722 study?
This clinical trial studies the following conditions: Articular Cartilage of the Femoral Condyle Between 2-6cm2.
What interventions are being tested in trial NCT01957722?
The interventions under investigation include: Microfracture (PROCEDURE), NOVOCART 3D (BIOLOGICAL).
Who is sponsoring clinical trial NCT01957722?
This trial is sponsored by Aesculap Biologics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01957722 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Idaho, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.